UBS O'Connor’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,583
| Closed | -$304K | – | 530 |
|
|
2024
Q1 | $304K | Sell |
28,583
-14,626
| -34% | -$155K | 0.01% | 354 |
|
|
2023
Q4 | $394K | Sell |
43,209
-74,071
| -63% | -$676K | 0.01% | 360 |
|
|
2023
Q3 | $1.22M | Sell |
117,280
-23,000
| -16% | -$239K | 0.02% | 304 |
|
|
2023
Q2 | $2.01M | Buy |
140,280
+40,187
| +40% | +$575K | 0.04% | 289 |
|
|
2023
Q1 | $715K | Buy |
+100,093
| New | +$715K | 0.02% | 427 |
|
|
2022
Q4 | – | Sell |
-154,093
| Closed | -$1.71M | – | 235 |
|
|
2022
Q3 | $1.71M | Buy |
154,093
+27,000
| +21% | +$299K | 0.02% | 656 |
|
|
2022
Q2 | $1.07M | Buy |
+127,093
| New | +$1.07M | 0.01% | 741 |
|